Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

FDA investigating five allergic reactions after Pfizer shot in U.S

Published 12/18/2020, 09:21 PM
Updated 12/18/2020, 10:40 PM
© Reuters. Covid-19 vaccines are adminstered at Massachusetts General Hospital in Boston

© Reuters. Covid-19 vaccines are adminstered at Massachusetts General Hospital in Boston

By Michael Erman

NEW YORK (Reuters) - The U.S. Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX)'s COVID-19 vaccine in the United States this week, a top FDA official said late on Friday.

Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said at a press conference that the allergic reactions had been reported in more than one state, including in Alaska.

Marks also said that a chemical called polyethylene glycol (PEG) that is an ingredient in the Pfizer vaccine - as well as the Moderna (NASDAQ:MRNA) Inc vaccine authorized on Friday - "could be the culprit" causing the reactions.

Marks said that allergic reactions to PEG could be somewhat more common than previously understood.

The cases in Alaska were similar to two cases reported last week in Britain.

Britain's medical regulator has said that anyone with a history of anaphylaxis, or severe allergic reactions to a medicine or food, should not be given the Pfizer-BioNTech COVID-19 vaccine.

But the U.S. Food and Drug Administration has said that most Americans with allergies should be safe to receive the vaccine. It said only people who have previously had severe allergic reactions to vaccines or ingredients in this particular vaccine should avoid getting the shot.

On Friday, the FDA said the Moderna vaccine should not be given to individuals with a known history of a severe allergic reactions to any components of the shot.

The regulator is also requiring that appropriate medical treatments for immediate allergic reactions must be available when the shot is administered in case of an anaphylactic reaction.

© Reuters. Covid-19 vaccines are adminstered at Massachusetts General Hospital in Boston

Pfizer could not be immediately reached for comment.

Latest comments

I'm curious that they're focusing on polyethylene glycol. It's commonly used in many products and pharmaceuticals like ibuprofen which coincidentally I am allergic to but not Cetirizine for allergies with the same ingredient.
PEG is an antifreeze ingredient
https://rumble.com/vbls73-finally-someone-steps-up-ands-tells-truth-about-coronavirus.html
What are you driving at Henrik Halim?
no thanks....I'll wait until I can see 100% ok or not...
In all vaccinations, it is impossible to have 100% ok rate. Even for normal flu vaccinations, some people develop allergic reactions.
"investigating around five allergic reactions" Around? Is five too large a number for the FDA to count up to?    They're not quite sure if it's 3, or 4, or 5, or 6, or 7? Or is "500" also "around five" to the FDA.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.